Scotiabank (BNS) Q3 2026 Earnings Call Transcript

Scotiabank reported Q3 adjusted net income of $2.97B (+16% revenue; +21% adjusted EPS to $2.28 from $1.88), with ROE rising 170 bps YoY to 14.2% and CET1 at 13.1%. The bank returned $8.3B to shareholders over the past 12 months (including $8.6M shares repurchased in the quarter) while maintaining positive operating leverage (3.9% YTD) despite $1.5B technology spend (+16% YoY) tied to AI infrastructure. Credit trends improved (PCL down 10 bps sequentially to 56 bps), but management flagged near-term capital headwinds from an AIRB migration in Q4 (~15 bps CET1 impact) and one-time deferred tax asset write-down risk in Q4 tied to Chile’s planned tax rate change.

Analysis

The clean read-through is not just “bank beat,” but that BNS is proving its mix shift can re-rate the franchise: wealth, transaction banking, and capital markets are now doing more of the earnings heavy lifting while capital returns stay aggressive. That matters for Canadian peers because it challenges the idea that only the biggest domestic deposit franchises deserve premium multiples; a bank can earn a higher ROE by monetizing client primacy across products, even if headline loan growth is only mid-single digits.

The second-order winner is the fee stack around BNS’s ecosystem: mutual funds, cards, GTB, and advisory should compound if operating deposits keep migrating in-house. The losers are mortgage- and spread-dependent competitors that need a steeper curve or faster loan growth to defend returns. But part of this quarter is cyclical: GBM benefited from constructive volatility and better issuance windows, which can reverse quickly if rates or equity volatility compress.

Near term, the main risk is Q4 capital friction: the AIRB migration and Chile tax write-down can mechanically dent CET1 and create a pause in buyback cadence just as investors extrapolate “14% is not the ceiling.” Over 1-3 months, any rise in Canadian mortgage delinquencies or tariff spillover into commercial credit would be enough to slow the re-rating. Over 6-18 months, the thesis breaks only if fee growth stalls and BNS is forced back into balance-sheet-heavy growth to defend share.

Consensus is probably underestimating how much of the upside is already in the capital return story, and overestimating how linear the earnings trajectory is from here. The better contrarian view is that this is a good execution story, not yet a clean duration asset: if markets normalize, the multiple may not expand much until Canadian banking ROE sustains above 20% without help from GBM.

Key Decisions for Investors

• Long BNS on any post-print pullback over the next 1-3 weeks; target a 6-12 month hold for buyback support and mix-shift compounding. Falsifier: CET1 falls materially below ~13% or Q4 capital actions force a slower repurchase pace.
• Pair trade: long BNS / short CM.TO for 1-3 months. BNS has a clearer fee-driven ROE upgrade path, while CM remains more exposed to domestic consumer and mortgage beta. Falsifier: Canadian credit metrics worsen broadly enough to hit BNS’s retail book.
• Add BNS to a Canadian bank basket on a relative basis versus RY and TD only if you want higher operating leverage and capital return; otherwise avoid paying up for the whole sector. The bet is on execution delta, not macro beta.
• Use BNS as a watchlist name for a short-vol or call-spread expression only after Q4, not immediately after the print; the near-term known capital headwinds make upside more path-dependent than the headline ROE suggests.